Cargando…
Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy
Hypercholesterolemia plays a crucial role in the development of atherosclerosis, but it remains an undertreated and underdiagnosed disease. Taking into consideration the high prevalence of lipid disorders, long duration of the asymptomatic course of the disease, life-threatening complications result...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095256/ https://www.ncbi.nlm.nih.gov/pubmed/37047830 http://dx.doi.org/10.3390/ijms24076858 |